［1］LA Torre，F Bray，RL Siegel，et al.Global cancer statistics，2012［J］.CA：A Cancer Journal for Clinicians，2015，65(2)：87-108.
[2]MA Liyuan，WU Yazhe，WANG Wen，et al.Interpretation of the report on cardiovascular diseases in China (2017)［J］.Chinese Journal of Cardiovascular，2018，23(1)：3-6.［马丽媛，吴亚哲，王文，等.《中国心血管病报告2017》要点解读［J］.中国心血管杂志，2018，23(1)：3-6.］
[3]SH Armenian，L Xu，B Ky，et al.Cardiovascular disease among survivors of adult-onset cancer：A community-based retrospective cohort study［J］.Journal of Clinical Oncology，2016，34(10)：1122-1130.
[4]K Esposito，P Chiodini，A Colao，et al.Metabolic syndrome and risk of cancer：A systematic review and meta-analysis［J］.Diabetes Care，2012，35(11)：2402-2411.
[5]K Wojcik-Cichy，E Koslinska-Berkan，A Piekarska.The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases［J］.Clinical and Experimental Hepatology，2018，4(1)：1-6.
[6]TANG Jiarong，WANG Daowen.The clinical stages，classifications and new therapeutic strategies of hypertension［J］.Chinese Journal of Practical Internal Medicine，2019，39(01)：11-15.［唐家荣，汪道文.高血压的分期分类及治疗策略［J］.中国实用内科杂志，2019，39(01)：11-15.］
[7]The Chinese Medical Association.Complications Chinese type 2 diabetes prevention guide (2017 edition)［J］.Chinese Journal Diabetes Mellitu，2018，10(1)：4-67.［中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）［J］.中华糖尿病杂志，2018，10(1)：4-67.］
[8]PENG Jubao.Diagnostic criterion& treatment of hyperuricemia［J］.Modern Diagnosis and Treatment，1997，8(04)：10-11.［彭聚宝.高尿酸血症的诊断标准及治疗［J］.现代诊断与治疗，1997，8(04)：10-11.］
[9]AN Yu，LIU Zhihong.A new classification criteria for gout and its development［J］.Chinese Journal of Nephrology Dialysis & Transplantion，2016，25(02)：165-169.［安玉，刘志红.痛风诊断标准的演变及新标准解读［J］.肾脏病与透析肾移植杂志，2016，25(02)：165-169.］
[10]WANG Jun.Interpretation of 2015 European Society of Cardiology guidelines for the diagnosis and management of pericardial diseases［J］.World Clinical Drugs，2016，37(05)：293-299.［王骏.2015欧洲心脏病学会心包疾病诊断和治疗指南解读［J］.世界临床药物，2016，37(05)：293-299.］
[11]REN Chonglei，JIANG Shengli.Interpretation of 2014 American heart valve disease guidelines［J］.Journal of Cardiovascular Surgery(Electronic Edition)，2015，4(03)：107-110.［任崇雷，姜胜利.2014年美国心脏瓣膜病指南解读［J］.心血管外科杂志(电子版)，2015，4(03)：107-110.］
[12]LUO Yiming，JIANG Chuhua，LUO Hua.The classification of cardiomyopathy and differential diagnosis［J］.Chinese Journal of Misdiagnostics，2004，4(10)：1624-1626.［罗一明，蒋初华，罗化.心肌病的分类与鉴别诊断［J］.中国误诊学杂志，2004，4(10)：1624-1626.］
[13]GUO Zeqi，WANG Qianyi，QI Xingshun，et al.Recommendations for the diagnosis and management of nonalcoholic fatty liver disease：Practice guidance from the American Association for the Study of Liver Diseases (2017)［J］.J Clin Hepatol，2017，33(12)：2275-2277.［郭泽淇，王倩怡，祁兴顺，等.《2017年美国肝病学会非酒精性脂肪性肝病诊疗指导》摘译［J］.临床肝胆病杂志，2017，33(12)：2275-2277.］
[14]HUANG Zhenhua.Progress in the diagnosis and treatment of arrhythmia［J］.Journal of New Medicine，2002，33(03)：135-136.［黄震华.心律失常的诊断和治疗进展［J］.新医学，2002，33(03)：135-136.］
[15]The Chinese Medical Association Cardiovascular Epidemiology Branch，the Cardiovascular Disease Magazine Editorial Board.Non ST-elevation acute coronary syndrome diagnosis and treatment guidelines［J］.The Chinese Journal of Cardiovascular Disease，2012，40(5)：353-367.［中华医学会心血管病学分会，中华心血管病杂志编辑委员会.非ST段抬高急性冠状动脉综合征诊断和治疗指南［J］.中华心血管病杂志，2012，40(5)：353-367.］
[16]The Chinese Medical Association Cardiovascular Epidemiology Branch，the Cardiovascular Disease Magazine Editorial Board.Diagnosis and treatment of acute ST segment elevation myocardial infarction［J］.The Chinese Journal of Cardiovascular Disease，2015，43(5)：380-393.［中华医学会心血管病学分会，中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南［J］.中华心血管病杂志，2015，43(5)：380-393.］
[17]The Chinese Medical Association Cardiovascular Epidemiology Branch of the Interventional Heart Disease Group.The stability of coronary heart disease diagnosis and treatment guidelines［J］.The Chinese Journal of Cardiovascular Disease，2018，46(9)：680-694.［中华医学会心血管病学分会介入心脏病学组.稳定性冠心病诊断与治疗指南［J］.中华心血管病杂志，2018，46(9)：680-694.］
[18]CHENG Yingzhang，LI Tao.Interpretation of european society of cardiology guidelines of European adult congenital heart disease(2010 edition)［J］.Jiangxi Medicine，2012，47(05)：396-400.［程应樟，李涛.欧洲成人先天性心脏病ESC指南解读(2010版)［J］.江西医药，2012，47(05)：396-400.］
[19]Nickhill Bhakta，Qi Liu，Frederick Yeo，et al.Cumulative burden of cardiovascular morbidity in paediatric，adolescent，and young adult survivors of Hodgkin's lymphoma：An analysis from the St Jude Lifetime Cohort Study［J］.The Lancet Oncology，2016，17(9)：1325-1334.
[20]SONG Feiyan，CHENG Leilei，CHEN Yongle,et al.Evaluation of subclinical dysfunction of left ventricle induced by anthracyclines in patients with difuse large B-cell lymphoma by real-time three dimensional echocardiography［J］.Chinese Journal of Diagnostics(Electronic Edition)，2015，3(03)：155-158.［宋飞艳，程蕾蕾，陈永乐，等.实时三维超声心动图评价淋巴瘤患者蒽环类药物化疗后左心室亚临床功能的价值［J］.中华诊断学电子杂志，2015，3(03)：155-158.］
[21]Carolyn Taylor，Paul McGale，Dorthe Brnnum，et al.Cardiac structure injury after radiotherapy for breast cancer：Cross-sectional study with individual patient data［J］.Journal of Clinical Oncology，2018，36(22)：2288-2296.
[22]Alan C Cameron，Rhian M Touyz，Ninian N Lang.Vascular complications of cancer chemotherapy［J］.The Canadian Journal of Cardiology，2016，32(7)：852-862.
[23]J Baech，SM Hansen，PE Lund，et al.Cumulative anthracycline exposure and risk of cardiotoxicity； a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines［J］.British Journal of Haematology，2018，183(5)：717-726.
[24]DN Friedman，ES Tonorezos，P Cohen.Diabetes and metabolic syndrome in survivors of childhood cancer［J］.Hormone Research in Paediatrics，2019，91(2)：118-127.
[25]S Casco，E Soto-Vega.Development of metabolic syndrome associated to cancer therapy：Review［J］.Hormones & Cancer，2016，7(5-6)：289-295.
[26]M Kim，IH Kim，MK Lim，et al.Increased prevalence of metabolic syndrome in adult cancer survivors：Asian first report in community setting［J］.Cancer Epidemiology，2019(58)：130-136.
[27]ZHU Wenling.The expert consensus interpretation of high uric acid hematic disease combined with cardiovascular disease for diagnosis and treatment［J］.Chinese Journal of Cardiovascular Medicine，2010，15(6)：412-414.［朱文玲.高尿酸血症合并心血管疾病诊治专家共识解读［J］.中国心血管杂志，2010，15(6)：412-414.］
[28]L Zanoli，A Di Pino，V Terranova，et al.Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome［J］.Nutrition，Metabolism，and Cardiovascular Diseases：NMCD，2018，28(12)：1222-1229.
[29]M Sakamoto，D Matsutani，Y Kayama.Possibility of a new therapeutic strategy for left ventricular dysfunction in type 2 diabetes［J］.Journal of Clinical Medicine Research，2018，10(11)：799-805.